November 20th, 2023
Program Resumption in Latin America
Starting November 20th, 2023, Olympus will resume receiving new requests for Grant support in Latin America.
This includes both financial and product requests (product support only available in Mexico, Brazil and Puerto Rico).
Please note that our standard 60-day rule applies. Therefore, the first eligible program date would be January 19th, 2024.
If you have any questions, please contact email@example.com.
Program Pause in Latin America
Due to high program volume, Olympus will not accept new requests for Grant support in Latin America between August 1st, 2023- November 20th , 2023.
This includes both financial and product requests.
We anticipate resuming review of requests after November 20th, 2023. We encourage interested parties to monitor this section of our website for any updates.
Please note that our standard 60-day rule applies. When we resume review of new requests, it will be for programs with dates after January 19th, 2024.
If you have any questions, please contact firstname.lastname@example.org
Microscopy Education Update
Evident Corporation announced in April 2023 that it has been acquired by private equity firm Bain Capital Private Equity from Olympus Corporation pursuant to the definitive agreement signed on August 29, 2022.
As a result of this, the Olympus Grants Committee is no longer considering requests for microscopy education programs. This includes financial and product-loan requests.
Please reach out directly to Evident to inquire about their Grant program and application process.
Microscopy Education Update
Olympus Corporation recently announced the completion of the separation of its Scientific Solutions business to a wholly-owned subsidiary, Evident Corporation. As a newly-established wholly-owned subsidiary, Evident continues to operate independently under the Olympus umbrella.
Evident microscopy is not currently accepting grant requests, but is working to establish a program.
As more information becomes available, updates will be posted in our Program Updates.
If you have any questions, please contact the Olympus Grants Team- Americas
Support Categories Update
The Olympus Grants Committee has temporarily paused review of the following categories:
- Financial support for clinical fellowships coordinated by Medical Societies.
- Product donations for medical mission trips.
- Product donations for training and educational facilities.
We encourage interested parties to continue to check back for updates in November 2022
Friday, January 28, 2022
Fellowship Priority Areas Update
The Olympus Grants Committee considers requests for clinical fellowships coordinated by medical societies.
Current priority areas include:
- advanced endoscopy
- interventional urology
- interventional pulmonology
Should you have any questions, please contact the Olympus Grants Team- Americas at 484-896-3939 or grants-Americas@olympus.com.
Wednesday, July 1, 2020
COVID- 19 Update - Program Pause Update
Olympus Corporation of the Americas (OCA) is currently working through the implications of the COVID-19 crisis on our support for grant activities.
Olympus remains dedicated to fulfilling its mission as a supplier of life-sustaining medical, life sciences, and industrial industries. So that we can focus our efforts, Olympus has made the decision to begin accepting new grant requests utilizing a phased approach.
Starting July 1, 2020, the Olympus Grants Committee will begin receiving new requests for financial support only. New requests for product support will not be considered at this time. Please note that the 60-day rule remains. Therefore, the first eligible program date would be August 30. Programs must be planned in accordance with CDC and local COVID-19 guidelines.
We ask for your patience regarding possible delays in the processing of new grant requests as we resume grant activity.
We encourage interested parties to continue to check back for updates regarding expanded support categories.
Should you have any questions, please contact the OCA Grants Team at 484-896-3939 or email@example.com.